Ovarian Serous Adenocarcinoma — Trials

Ovarian Serous Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

151 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 69
Recruiting: 29
Ph III recruiting: 4
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 42.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (20)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04458597	Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.	completed	N/A	23	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER	1	Aug 1, 2025	clinicaltrials

Data updated 23 days agoSource updated Aug 1, 2025source: clinicaltrials